Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV).

Journal article

McNaughton AL. et al, (2019), Sci Rep, 9

Rolling circle amplification and nanopore-based deep sequencing of full-length HBV genomes

Conference paper

Mcnaughton A. et al, (2018), JOURNAL OF HEPATOLOGY, 68, S762 - S762

Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing.

Journal article

van der Ree MH. et al, (2017), Antiviral Res, 146, 139 - 145

T Cell Functionality in Chronic Hepatitis C Patients Treated With the Anti-miR-122 RG-101


Stelma F. et al, (2016), HEPATOLOGY, 64, 731A - 731A

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.

Journal article

Kelly C. et al, (2016), Hepatology, 63, 1455 - 1470

Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCR.

Journal article

Bonsall D. et al, (2016), Emerg Infect Dis, 22, 671 - 678

Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.

Journal article

Kelly C. et al, (2015), Eur J Immunol, 45, 309 - 316

Global distribution and prevalence of hepatitis C virus genotypes

Journal article

Messina JP. et al, (2015), Hepatology, 61, 77 - 87

Load More